Loading clinical trials...
Loading clinical trials...
Factor XII-associated Cold Autoinflammatory Syndrome (FACAS) Linked to Kallikrein-kinin Pathology: Proof of Concept Treatment With Lanadelumab (DX-2930)
Conditions
Interventions
Lanadelumab
Locations
1
Germany
Charite University, Berlin, Germany
Berlin, Germany
Start Date
October 5, 2020
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
January 8, 2024
Lead Sponsor
Charite University, Berlin, Germany
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions